Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus

Homocysteine Disrupts Balance between MMP-9 and Its Tissue Inhibitor in Diabetic Retinopathy: The Role of DNA Methylation

(2020) Ghulam Mohammad et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Concentrations of Selected Cytokines and Vascular Endothelial Growth Factor in Aqueous Humor and Serum of Diabetic Patients

(2020) Katarina Cvitkovic et al.   Seminars in Ophthalmology

Tightening the retinal glia limitans attenuates neuroinflammation after optic nerve injury

(2020) Evy Lefevere et al.   GLIA

Risks and Challenges in Interpreting Simultaneous Analyses of Multiple Cytokines

(2020) Isabel B. Pfister et al.   Translational Vision Science & Technology

Mitochondrial Stability in Diabetic Retinopathy: Lessons Learned From Epigenetics

(2019) Renu A. Kowluru   DIABETES

MMP targeting in the battle for vision: Recent developments and future prospects in the treatment of diabetic retinopathy

(2019) Justyna Drankowska et al.   LIFE SCIENCES

Regional Expression of Act-MMP3 Contributes to the Selective Loss of Neurons in Ganglion Cell Layers following Acute Retinal ischemia/Reperfusion Injury

(2019) Tu Hu et al.   CURRENT EYE RESEARCH

TGF-β1 – A truly transforming growth factor in fibrosis and immunity

(2019) Monika Lodyga et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Matrix metalloproteinase-3 in brain physiology and neurodegeneration

(2019) Anna Lech et al.   Advances in Clinical and Experimental Medicine

Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema

(2018) Roxane J. Hillier et al.   JAMA Ophthalmology

RELATIONSHIP BETWEEN STAGES OF DIABETIC RETINOPATHY AND LEVELS OF BRAIN-DERIVED NEUROTROPHIC FACTOR IN AQUEOUS HUMOR AND SERUM

(2018) Ayşe Güzin Taşlipinar Uzel et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Pericytes in diabetes-associated vascular disease

(2016) Nele Warmke et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Inhibiting Matrix Metalloproteinase 3 Ameliorates Neuronal Loss in the Ganglion Cell Layer of Rats in Retinal Ischemia/Reperfusion

(2016) Tu Hu et al.   NEUROCHEMICAL RESEARCH

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients

(2016) Jin-woo Kwon et al.   PLoS One

Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

(2016) Yong-chao Qiao et al.   Journal of Diabetes Research

Deletion of Ocular Transforming Growth Factor β Signaling Mimics Essential Characteristics of Diabetic Retinopathy

(2015) Barbara M. Braunger et al.   AMERICAN JOURNAL OF PATHOLOGY

From Pathobiology to the Targeting of Pericytes for the Treatment of Diabetic Retinopathy

(2015) Joseph F. Arboleda-Velasquez et al.   Current Diabetes Reports

Matrix metalloproteinases in the mouse retina: a comparative study of expression patterns and MMP antibodies

(2015) Lies De Groef et al.   BMC Ophthalmology

Biological Activity Differences between TGF-β1 and TGF-β3 Correlate with Differences in the Rigidity and Arrangement of Their Component Monomers

(2014) Tao Huang et al.   BIOCHEMISTRY

Role of Inflammation in Diabetic Macular Edema

(2014) Hidetaka Noma et al.   OPHTHALMOLOGICA

Relationship between Serum Transforming Growth Factorβ1 Concentrations and the Duration of Type 1 Diabetes Mellitus in Children and Adolescents

(2013) Katarzyna Zorena et al.   MEDIATORS OF INFLAMMATION

Serum Concentrations of Transforming Growth Factor-Beta 1 in Predicting the Occurrence of Diabetic Retinopathy in Juvenile Patients with Type 1 Diabetes Mellitus

(2013) Katarzyna Zorena et al.   Journal of Diabetes Research

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

(2012) J. W. Y. Yau et al.   DIABETES CARE

Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9

(2012) Renu A Kowluru et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Methylglyoxal induces hyperpermeability of the blood–retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases

(2012) Junghyun Kim et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy

(2012) Rob J. Van Geest et al.   Journal of Cell Communication and Signaling

Abrogation of MMP-9 Gene Protects Against the Development of Retinopathy in Diabetic Mice by Preventing Mitochondrial Damage

(2011) Renu A. Kowluru et al.   DIABETES

Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium

(2010) Weiyong Shen et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

The Transforming Growth Factor-  Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy

(2009) C. Gerhardinger et al.   DIABETES

TGF-β Is Required for Vascular Barrier Function, Endothelial Survival and Homeostasis of the Adult Microvasculature

(2009) Tony E. Walshe et al.   PLoS One